Ligand validation:8IPW

AR6: [(2R,3S,4R,5R)-5-(6-AMINOPURIN-9-YL)-3,4-DIHYDROXY-OXOLAN-2-YL]METHYL [HYDROXY-[[(2R,3S,4R,5S)-3,4,5-TRIHYDROXYOXOLAN-2-YL]METHOXY]PHOSPHORYL] HYDROGEN PHOSPHATE

AR6 is a Ligand Of Interest in 8IPW designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8IPW_AR6_A_501	74%	1%	0.124	0.955	5.53	2.41	13	7	0	0	100%	1
8IPW_AR6_B_501	67%	1%	0.128	0.938	5.55	2.18	12	7	2	0	100%	1
8DMR_AR6_A_501	88%	57%	0.105	0.98	0.59	1.05	-	3	0	0	100%	1
8DMS_AR6_B_501	50%	59%	0.16	0.91	0.6	0.93	-	3	0	0	100%	0.7794
7TX0_AR6_A_201	100%	21%	0.04	0.995	2.27	1.23	9	2	0	0	100%	0.954
7TWW_AR6_A_201	100%	28%	0.043	0.996	1.88	1.17	6	2	0	0	100%	0.988
7TWX_AR6_A_201	100%	23%	0.044	0.995	2.15	1.23	8	2	0	0	100%	0.953
7TWV_AR6_A_201	100%	25%	0.048	0.996	1.98	1.23	6	2	0	0	100%	0.983
7TX1_AR6_A_201	100%	19%	0.046	0.994	2.39	1.23	10	2	0	0	100%	0.954

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.